Scott A. Kelly
2021
In 2021, Scott A. Kelly earned a total compensation of $3.3M as Chief Medical Officer at CytoDyn.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $107,345 |
| Option Awards | $1,059,500 |
| Salary | $700,000 |
| Stock Awards | $1,227,782 |
| Other | $37,830 |
| Total | $3,332,457 |
Kelly received $1.2M in stock awards, accounting for 37% of the total pay in 2021.
Kelly also received $200K in bonus, $107.3K in non-equity incentive plan, $1.1M in option awards, $700K in salary and $37.8K in other compensation.
Rankings
In 2021, Scott A. Kelly's compensation ranked 4,010th out of 12,415 executives tracked by ExecPay. In other words, Kelly earned more than 67.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,010 out of 12,415 | 68th |
Division Manufacturing | 1,643 out of 5,508 | 70th |
Major group Chemicals And Allied Products | 680 out of 2,378 | 71st |
Industry group Drugs | 604 out of 2,099 | 71st |
Industry Pharmaceutical Preparations | 423 out of 1,549 | 73rd |
Source: SEC filing on October 26, 2022.
Kelly's colleagues
We found two more compensation records of executives who worked with Scott A. Kelly at CytoDyn in 2021.